Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts Ann C. McKeeThor D. SteinDaniel H. Daneshvar Review Open access 10 February 2023 Pages: 371 - 394
Repetitive head impacts and chronic traumatic encephalopathy are associated with TDP-43 inclusions and hippocampal sclerosis Raymond NicksNathan F. ClementThor D. Stein Original Paper 21 January 2023 Pages: 395 - 408
Retinal pathological features and proteome signatures of Alzheimer’s disease Yosef KoronyoAltan RentsendorjMaya Koronyo-Hamaoui Original Paper Open access 11 February 2023 Pages: 409 - 438
Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex Natalie MatosinJanine ArlothElisabeth B. Binder Original Paper Open access 02 February 2023 Pages: 439 - 459
IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity Anastasia GeladarisSilke Häusser-KinzelMartin S. Weber Original Paper Open access 01 March 2023 Pages: 461 - 477
Variants in DTNA cause a mild, dominantly inherited muscular dystrophy Andres NascimentoChristine C. BruelsDaniel Natera-de Benito Original Paper 17 February 2023 Pages: 479 - 496
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas Vivian TangRufei LuDavid A. Solomon Correspondence Open access 01 February 2023 Pages: 497 - 500
Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma A. Basit KhanCollin W. EnglishAkash J. Patel Correspondence 02 February 2023 Pages: 501 - 503
SMARCA4-associated schwannomatosis Fiona Chan-Pak-ChoonCarla RocaWilliam D. Foulkes Correspondence 14 February 2023 Pages: 505 - 507
Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease Antonio Boza-SerranoRocío RuizTomas Deierborg Correction Open access 15 February 2023 Pages: 509 - 510
Correction to: Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification Michaela-Kristina KeckMartin SillDavid T. W. Jones Correction Open access 14 February 2023 Pages: 511 - 514